AIM
OME

Acrospire Investment Management’s Omega Protein OME Stock Holding History

Acrospire Investment Management’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10,710
Closed -$215K – 2794
2017
Q1 		$215K Sell
10,710
-10,145
-49% -$236K 0.18% 24
2016
Q4 		$522K Buy
20,855
+9,992
+92% +$236K 0.21% 16
2016
Q3 		$254K Buy
10,863
+7,950
+273% +$187K 0.17% 61
2016
Q2 		$58K Buy
+2,913
New +$54.4K 0.04% 947

Other funds holding OME

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Acrospire Investment Management's OME Position: Q2 2017 in Review

Acrospire Investment Management sold out of Omega Protein (OME) in Q2 2017, closing a stake of 10,710 shares — an estimated $215K sold.

Acrospire Investment Management first reported a position in OME in Q2 2016 and held it in 4 quarters. The position peaked at $522K in Q4 2016. 140 funds tracked by Wall St. Rank hold OME as of Q2 2017.

  • Acrospire Investment Management reported no remaining Omega Protein position as of Q2 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 10,710 Omega Protein shares in Q2 2017, an estimated $215K.
  • Acrospire Investment Management first reported a position in Omega Protein in Q2 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Omega Protein position peaked at $522K in Q4 2016.
  • 140 funds tracked by Wall St. Rank held Omega Protein as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.